SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001013762-23-001393
Filing Date
2023-10-04
Accepted
2023-10-04 09:00:24
Documents
6
Period of Report
2023-10-04

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea186227-6k_altamirather.htm 6-K 12899
2 NOTICE TO SHAREHOLDERS DATED OCTOBER 04, 2023 ea186227ex99-1_altamirather.htm EX-99.1 32716
3 PROXY CARD FOR THE SPECIAL GENERAL MEETING OF SHAREHOLDERS ea186227ex99-2_altamirather.htm EX-99.2 6021
4 GRAPHIC ex99-1_001.jpg GRAPHIC 7450
5 GRAPHIC ex99-2_001.jpg GRAPHIC 536954
6 GRAPHIC ex99-2_002.jpg GRAPHIC 436143
  Complete submission text file 0001013762-23-001393.txt   1403680
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36582 | Film No.: 231306668
SIC: 2834 Pharmaceutical Preparations